Stay updated on GSK2857916 Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.

Latest updates to the GSK2857916 Dose Escalation Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedPublications section now states that PubMed publications are automatically filled from PubMed, and the page revision is updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

- Check20 days agoChange DetectedRemoved the government funding status notice from the page; the study details and other information remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check35 days agoChange DetectedThe new screenshot mirrors the prior version, with only minor layout adjustments and no changes to core study details such as title, conditions, interventions, primary outcomes, eligibility, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedRelated topics updated to include Multiple Myeloma and MedlinePlus Genetics; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedCore page content updated to include a funding-status notice and operating-status guidance, plus a version upgrade from v3.1.0 to v3.2.0.SummaryDifference0.9%

- Check71 days agoChange Detected- Updated medical term from 'Plasma cell myeloma' to 'Multiple myeloma'. - Page revision bumped from v3.0.2 to v3.1.0.SummaryDifference0.1%

Stay in the know with updates to GSK2857916 Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Dose Escalation Clinical Trial page.